Open-label Extension Study Of RN624
Recruiting in Palo Alto (17 mi)
+35 other locations
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Phase 2
Waitlist Available
Sponsor: Pfizer
No Placebo Group
Prior Safety Data
Trial Summary
What is the purpose of this trial?
Study RN624-CL007 is planned to be an open-label protocol to enroll subjects who have previously participated in Study No. RN624-CL006. In this study, subjects will receive RN624 on an open-label basis.
Eligibility Criteria
Inclusion Criteria
Enrolled in Study RN624-CL006
Treatment Details
Interventions
- RN624 (Monoclonal Antibodies)
Participant Groups
1Treatment groups
Experimental Treatment
Group I: 1Experimental Treatment1 Intervention
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
The Center for Rheumatology and Bone ResearchWheaton, MD
Pharmacotherapy Research Associates IncorporatedZanesville, OH
New Orleans Center for Clinical ResearchKnoxville, TN
Radiant Research - San AntonioSan Antonio, TX
More Trial Locations
Loading ...
Who Is Running the Clinical Trial?
PfizerLead Sponsor